Translational research - A new entity?

Acta Oncologica

Volumn 40, Issue 8, 2001, Pages 995-999

  Dische, Stanley ^a   Saunders, Michele ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL LABORATORIES; PATIENT TREATMENT; TUMORS;

CLINICAL PROTOCOLS;

ONCOLOGY;

CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CLINICAL PROTOCOL; CONFERENCE PAPER; HUMAN; PRIORITY JOURNAL; RADIATION RESPONSE; TRANSLATION REGULATION; TREATMENT PLANNING; UNITED KINGDOM;

CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HISTORY, 20TH CENTURY; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICAL ONCOLOGY; NEOPLASMS; PORTRAITS; RESEARCH DESIGN;

EID: 0035702762     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860152708297     Document Type: Conference Paper

References (27)

1. Translational research
2. Animal systems for translational research in radiation oncology
3. High pressure oxygen and radiotherapy
4. The clinical science of radiation oncology. Regaud Lecture, Malmo, 1992
5. Hypoxic cell radiosensitisation - Clinical relevance in
6. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85
7. Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift
8. Radiotherapy employing three fractions on twelve consecutive days
9. Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: An interim report
10. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
11. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer
12. An uncharted country
13. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts
14. Estro Mitre 2000
15. Acute mucositis in the stimulated oral mucosa of patients during radiotherapy for head and neck cancer
16. About tolerance and quality. An important notice to all radiation oncologists
17. The CHART regimen and morbidity
18. A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multicentre trial
19. Accelerated radiation therapy in non-small cell lung cancer
20. Updated data for CHART in NSCLC: A missed opportunity. Letter to editor
21. The hazard of accelerated tumour clonogen repopulation during radiotherapy
22. Repair capacity and kinetics for human mucosa and epithelial tumors in the head and neck: Clinical data on the effect of changing the time interval between multiple fractions per day in radiotherapy
23. Biological factors influencing optimum fractionation in radiation therapy
24. Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy week end less) in non-small cell lung cancer
25. Extrapolations from laboratory and preclinical studies for the use of carbogen and nicotinamide in radiotherapy
26. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide